jump to example.com
newsletter linked in

UVa. makes breakthrough in peripheral arterial disease

uva-logoA discovery at the University of Virginia School of Medicine is opening up new avenues for treating peripheral arterial disease (PAD), a common circulation problem that afflicts millions of Americans. Researchers have pinpointed a key genetic regulator that appears to controls the ability to adapt to blockages in blood vessels – and it turns out to be a tiny RNA molecule.

The finding gives researchers a new target for potential therapies to treat patients with peripheral arterial disease, as well as allowing them to better understand the progression of the disease in patients.

“Why does one person with peripheral arterial disease remain stable and do well while another person has a much worse clinical course? We need to begin to unravel these types of questions,” said Brian Annex, MD, division chief of cardiovascular medicine at UVA. “When we see a patient with peripheral arterial disease, the reality is that information we get out of their age, gender, risk factors and basic clinical measures doesn’t tell us how the patient is going to do. We’re often left with uncertainty. I think as we begin to understand the [implications of the discovery] we will better understand PAD and open up entirely new treatment approaches.”

The Causes of PAD
Peripheral arterial disease is caused by atherosclerosis that builds up inside the arteries and impedes blood flow, most often to the legs. Treatments to date have been ineffective at improving blood flow in PAD.

UVA’s discovery may help change that. The researchers determined that a specific “microRNA” molecule, microRNA-93, appears to control the expression of several related genes in mouse models of PAD.

“This microRNA had profound effects on both endothelial and muscle cells. Whether we used a gain of function or loss of function, in pretty much every situation, whenever we got a gain of function or a therapeutic benefit, the microRNA was present at a higher level and suppressed three genes,” Annex said. “Whenever you had less miR-93, you had more expression of these and a poorer response to injury/repair.”

Overturning Orthodoxy
Scientists once thought that microRNAs were effectively junk with no ability to generate proteins. But recently microRNAs have emerged as major regulators of how genes respond to injury. In the case of PAD, the UVA researchers found, microRNA-93 directs how genes react to the restriction in blood supply.

“The central dogma of molecular biology — that DNA makes RNA and RNA makes protein — is probably wrong more often than it’s right,” Annex said.

New Treatments for Peripheral Arterial Disease
UVA’s discovery presents an exciting new possibility of treating PAD by boosting the effects of microRNA-93, Annex said.

“To date, drugs used to treat patients with PAD have always tried to target a single gene, whereas it’s very clear this microRNA has significant effects on multiple related genes,” Annex said. “This opens up an entirely new paradigm for treating and understanding peripheral arterial disease.”

While more research needs to be done, Annex foresees several potential ways doctors could manipulate microRNA-93 to target PAD and avoid problems that plague other efforts to develop new treatments.

“One can imagine a direct strategy of delivering the microRNA, one can imagine a strategy to change the body’s own expression of the microRNA, one can try to figure out ways to prevent the breakdown of the microRNA,” he said. “Many of the strategies that are being set up to treat patients with peripheral arterial disease try to grow new blood vessels. Our microRNA will grow blood vessels, but what’s absolutely fascinating is that … it not only makes new blood vessels, but the blood vessels have structure and architecture and may very well get around the prior problems where drugs cause the development of leaky, malformed blood vessels.”

Published in 
Circulation
The new findings have been detailed in a paper published online by the journal Circulation. The article was authored by Surovi Hazarika, MD, PhD; Charles R. Farber, PhD; Ayotunde O. Dokun, MD, PhD; Achilleas N. Pitsillides, PhD; Tao Wang, MD, PhD; R. John Lye, PhD; and Annex.

 
Top Stories
a

Nothing political about this McAuliffe 'investigation': Nothing at all

Republicans are suing Virginia Gov. Terry McAuliffe over his move to restore voting rights to 206,000 ex-felons.

Republicans to file suit against McAuliffe executive order on voting rights

Republicans are filing suit to halt enforcement of Gov. Terry McAuliffe’s order restoring the political rights of more than 206,000 convicted felons.

Gas prices reach 2016 high

The national average price of gasoline increased slightly over the past week, and has reached a new high for 2016.

Augusta County extends Internet service survey

Residents and businesses have actively completed a survey to assist in developing a plan for internet service in Augusta County.

Virginia jobless rate drops below 4 percent

Virginia’s seasonally adjusted unemployment rate declined by 0.1 percentage point in April and is now at 3.9 percent.

Tommy Dreamer is right: No more head chairshots

ECW Original Tommy Dreamer said in a recent interview that wrestling needs to do away with unprotected chairshots to the head.

Crystal Graham talks suicide prevention on WKDW

Crystal Graham joins Kris Neil with WKDW-900AM for Mental Health Mondays, part of the #MentalHealthintheValley campaign.

Small newspapers don't like new overtime rules

The newspaper industry has an issue with the new overtime pay rules. Big surprise there, if you know anything about the print news business.

Honey bees, comb home

According to Fred Hollan of Valley Bee Supply, the two main contributors to bee fatality are pesticides and a mite called a varroa.

Waynesboro Greenway expansion to begin this summer

The next segment of the South River Greenway in Waynesboro will be under construction this summer.

 
Discussion
 
Recent News

AFP Business

AFP: The Magazine

In 2015, Augusta Free Press brought back our print magazine under a new name, Augusta Free Press: The Magazine.
.
 

Advertise on AFP

Get information on AFP readership and advertising online with us.
.
 

AFP Classes

Augusta Free Press offers a series classes on website design, marketing strategy, social media, event planning and more.
.
 

AFP Web Design

Get your business online for as little as $1,299. We take care of all facets of web design – visual design, layout design and content development.
.
 

AFP Graphic Design

Whether you need a fresh business card design, rack card, ad, flyer or full magazine design, we can help with all your graphic-design needs.
.

AFP Marketing/PR

Augusta Free Press manages advertising campaigns for small- and medium-sized businesses across Virginia. You don’t need to hire a full-time marketing coordinator. Bring the experience of the Augusta Free Press team to work for you – for a fraction of the cost.
.
 

AFP Search Engine Optimization

The prettiest website in the world is like a tree falling in the forest with no one there to hear it. If your website hasn’t been search engine optimized, no one is going to see it or hear it – and it’s not going to work for you.

 

AFP Video/Audio

Web videos, TV and radio commercials, DVDs – Augusta Free Press LLC has you covered when it comes to video and audio production.
.
 

AFP Book Publishing

Augusta Free Press Publishing has produced books in-house and assisted more than 17 authors with book publishing and production services since 2003. Whether you need a cover, layout, or need help from start to finish, we are here to help!
.